AbstractHuman gene 2 relaxin (RLX) is a member of the insulin superfamily and is a multi‐functional factor playing a vital role in pregnancy, aging, fibrosis, cardioprotection, vasodilation, inflammation, and angiogenesis. RLX is currently applied in clinical trials to cure among others acute heart failure, fibrosis, and preeclampsia. The synthesis of RLX by chemical methods is difficult because of the insolubility of its B‐chain and the required laborious and low yielding site‐directed combination of its A (RLXA) and B (RLXB) chains. We report here that oxidation of the Met25residue of RLXB improves its solubility, allowing its effective solid‐phase synthesis and application in random interchain combination reactions with RLXA. Linear Met(O)25‐RLX B‐chain (RLXBO) reacts with a mixture of isomers of bicyclic A‐chain (bcRLXA) giving exclusively the native interchain combination. Applying this method Met(O)25‐RLX (RLXO) was obtained in 62% yield and was easily converted to RLX in 78% yield, by reduction with ammonium iodide. Copyright © 2010 European Peptide Society and John Wiley & Sons, Ltd.